Opioid patient controlled analgesia use during the initial experience with the IMPROVE PCA trial: A phase III analgesic trial for hospitalized sickle cell patients with painful episodes

Carlton D. Dampier, Wally R. Smith, Hae Young Kim, Carrie Greene Wager, Margaret C. Bell, Caterina P. Minniti, Jeffrey Keefer, Lewis Hsu, Lakshmanan Krishnamurti, A. Kyle Mack, Donna Mcclish, Sonja M. Mckinlay, Scott T. Miller, Ifeyinwa Osunkwo, Phillip Seaman, Marilyn J. Telen, Debra L. Weiner

Research output: Contribution to journalArticle

20 Scopus citations
Original languageEnglish (US)
Pages (from-to)E70-E73
JournalAmerican Journal of Hematology
Volume86
Issue number12
DOIs
StatePublished - Dec 1 2011
Externally publishedYes

ASJC Scopus subject areas

  • Hematology

Cite this

Dampier, C. D., Smith, W. R., Kim, H. Y., Wager, C. G., Bell, M. C., Minniti, C. P., Keefer, J., Hsu, L., Krishnamurti, L., Mack, A. K., Mcclish, D., Mckinlay, S. M., Miller, S. T., Osunkwo, I., Seaman, P., Telen, M. J., & Weiner, D. L. (2011). Opioid patient controlled analgesia use during the initial experience with the IMPROVE PCA trial: A phase III analgesic trial for hospitalized sickle cell patients with painful episodes. American Journal of Hematology, 86(12), E70-E73. https://doi.org/10.1002/ajh.22176